Table 2.
Percentage of times a variable was selected for each data set (A, B, C, D) and the average of those percentages across all data sets.
| Variable | Data set (%) |
|
|||
| A | B | C | Average | ||
| Sex | 0 | 20 | 0 | 7 | |
| Marital status | 20 | N/Aa | N/A | 20 | |
| Year of diagnosis | 20 | 40 | 20 | 27 | |
| Age at diagnosis | 40 | 40 | N/A | 40 | |
| Year of disease onset | 60 | 20 | 100 | 60 | |
| Age at disease onset | 20 | 20 | N/A | 20 | |
| Year of start of the first biologic therapy | 40 | 60 | 20 | 40 | |
| Age at start of the first biologic therapy | 60 | 40 | N/A | 50 | |
| Years from diagnosis to start of the first biologic therapy | 20 | 20 | N/A | 20 | |
| Disease years until start of the first biologic therapy | 20 | 20 | N/A | 20 | |
| HLA-B27b | 0 | 40 | 100 | 47 | |
| Employment status before disease | 40 | 20 | N/A | 30 | |
| Employment status at baseline | 20 | 20 | 0 | 13 | |
| Years of education | 100 | 100 | N/A | 100 | |
| Smoking | 40 | 40 | 20 | 33 | |
| Alcohol | 20 | 40 | 20 | 27 | |
| Weight | 40 | N/A | N/A | 40 | |
| Height | 20 | N/A | 20 | 20 | |
| BMI | 40 | N/A | N/A | 40 | |
| Number of pathologies | 20 | 0 | N/A | 10 | |
| Biologic | 20 | 20 | 20 | 20 | |
| Concomitant DMARDc | 0 | 20 | 0 | 7 | |
| Concomitant corticoid | 60 | 20 | 20 | 33 | |
| Baseline CRPd | 20 | 0 | 20 | 13 | |
| Baseline ESRe | 40 | 20 | 40 | 33 | |
| Baseline BASDAIf | 40 | 0 | 60 | 33 | |
| Baseline BASFIg | 80 | 100 | 40 | 73 | |
| Baseline ASDASh | 60 | 40 | 60 | 53 | |
aN/A: not applicable.
bHLA-B27: human leukocyte antigen B27.
cDMARD: disease-modifying antirheumatic drug.
dCRP: C-reactive protein.
eESR: erythrocyte sedimentation rate.
fBASDAI: Bath Ankylosing Spondylitis Disease Activity Index.
gBASFI: Bath Ankylosing Spondylitis Functional Index.
hASDAS: Ankylosing Spondylitis Disease Activity Score.